Inventor · disambiguated record
Laura Hix Glickman
Also filed as: GLICKMAN LAURA H · GLICKMAN LAURA HIX
15 granted patents·9 pending applications·138 citations·filing 2013–2025
92Inventor score
Top patents by PatentIndex Score
24 records- 0195US9724408B2Compositions and methods for activating stimulator of interferon gene-dependent signallingADURO BIOTECH INC·Filed 2014·Granted Aug 8, 2017·54 cites·6 claims
- 0295US9695212B2Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and useADURO BIOTECH INC·Filed 2013·Granted Jul 4, 2017·48 cites·11 claims
- 0389US11779612B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2019·Granted Oct 10, 2023·3 cites·60 claims
- 0489US11168326B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2018·Granted Nov 9, 2021·5 cites·38 claims
- 0589US10449211B2Compositions and methods for activating “stimulator of interferon gene”—dependent signallingADURO BIOTECH INC·Filed 2016·Granted Oct 22, 2019·7 cites·10 claims
- 0689US10414789B2Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and useADURO BIOTECH INC·Filed 2017·Granted Sep 17, 2019·8 cites·12 claims
- 0788US11242528B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2019·Granted Feb 8, 2022·3 cites·35 claims
- 0886US10653774B2Compositions and methods for activating “stimulator of interferon gene”-dependent signallingADURO BIOTECH INC·Filed 2017·Granted May 19, 2020·5 cites·9 claims
- 0984US12024709B2Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironmentACTYM THERAPEUTICS INC·Filed 2020·Granted Jul 2, 2024·2 cites·47 claims
- 1084US10906930B2Compositions and methods for activating “stimulator of interferon gene”-dependent signallingADURO BIOTECH INC·Filed 2016·Granted Feb 2, 2021·3 cites·12 claims
- 1180US12226439B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2022·Granted Feb 18, 2025·0 cites·41 claims
- 1280US2025345369A1Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1379US12201653B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2022·Granted Jan 21, 2025·0 cites·29 claims
- 1471US12357661B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2020·Granted Jul 15, 2025·0 cites·37 claims
- 1571US12012600B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2021·Granted Jun 18, 2024·0 cites·32 claims
- 1661US11040053B2Compositions and methods for activating “stimulator of interferon gene”13 dependent signallingCHINOOK THERAPEUTICS INC·Filed 2019·Granted Jun 22, 2021·0 cites·10 claims
- 1761US2024293478A1Immunostimulatory bacteria for converting macrophages into a phenotype amenable to treatment, and companion diagnostic for identifying subjects for treatmentACTYM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1861US2020282049A1Compositions and methods for activating "stimulator of interferon gene"-dependent signallingADURO BIOTECH INC·Filed 2020·Application pending·0 cites
- 1958US2022154136A1Immunostimulatory bacteria delivery platforms and their use for delivery of therapeutic productsACTYM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2055US2022380720A1Immunostimulatory bacteria delivery platforms and their use for delivery of therapeutic productsACTYM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2153US2022119824A1Immunostimulatory bacteria-based vaccines, therapeutics, and rna delivery platformsACTYM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2253US2022135980A1Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironmentACTYM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2350US2016287623A1Use of sting agonist as cancer treatmentUNIV CHICAGO·Filed 2014·Application pending·0 cites
- 2445US2018028553A1Use of sting agonist as cancer treatmentUNIV CHICAGO·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laura Hix Glickman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →